Technical & Clinical Profile: Ava Force 200 mg Tablets (Avanafil)
Optimizing a high-demand inventory pipeline for modern, fast-acting urological medications requires a reliable trade partner. Ernest Impex, trading internationally under the Group of Ernest Pharmaceutical Pvt. Ltd., stands as a premier global exporter, bulk supplier, and institutional distributor of certified Ava Force 200 mg tablets (Avanafil). We coordinate highly compliant, climate-monitored distribution pathways originating from state-of-the-art manufacturing hubs in India directly to licensed commercial pharmacies, hospital procurement groups, and institutional networks in Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica).
Product Overview & Comprehensive Clinical Profile
Ava Force 200 mg tablets contain Avanafil, a cutting-edge, second-generation selective phosphodiesterase type 5 (PDE5) inhibitor. Chemically known as (S)-4-[(3-chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide, it represents the latest advancement in oral therapeutics for male erectile dysfunction (ED). The 200 mg strength represents the maximum therapeutic dosage ceiling, calibrated for robust efficacy, exceptionally rapid onset of action, and improved drug selectivity.
Primary Clinical Indications & Therapeutic Scope
Ava Force 200 mg oral tablets are engineered to manage and resolve complex presentations within urological and sexual medicine frameworks:
Treatment of Erectile Dysfunction (ED): Indicated for the treatment of erectile dysfunction (impotence) in adult men, establishing the consistent capability to achieve and sustain a penile erection firm enough for satisfactory sexual performance.
Rapid-Response Intervention: Highly valued in clinical settings where first-generation PDE5 inhibitors (such as Sildenafil) demonstrate undesirable onset lag times, providing predictable therapeutic support in as little as 15 minutes.
Alternative in Post-Prostatectomy Cases: Often evaluated by specialists for penile rehabilitation protocols following nerve-sparing radical prostatectomy.
Advanced Molecular Mechanism of Action
Selective PDE5 Inhibition: During localized sexual arousal, nitric oxide (NO) is released, stimulating the guanylate cyclase enzyme to synthesize cyclic guanosine monophosphate (cGMP). cGMP triggers smooth muscle relaxation and increased blood flow into the penis.
cGMP Preservation: Ava Force 200 mg selectively binds to and inhibits the PDE5 enzyme, preventing it from breaking down cGMP. This sustained elevation of cGMP enhances the physiological erectile response.
Isolating Target Receptors: Compared to older compounds, Avanafil displays significantly higher selectivity for PDE5 over other related isoenzymes (such as PDE6 in the retina, or PDE11 in skeletal muscle), which minimizes the risk of vision distortions and muscular aches.
Biochemical Architecture & Pharmacokinetics
Ultra-Rapid Absorption: Following oral administration, Avanafil is absorbed rapidly, reaching maximum plasma concentrations ($T_{max}$
Metabolic Pathway: Extensively metabolized by hepatic enzymes, primarily via the CYP3A4 pathway and secondarily through CYP2C9.
Half-Life Profile: Features an effective terminal elimination half-life of approximately 3 to 5 hours, delivering a targeted therapeutic window that avoids prolonged systemic drug accumulation.
Elimination Vectors: Excreted primarily as metabolites via the feces (approximately 62%) and secondarily through the urine (approximately 21%).
Detailed Side Effects & Comprehensive Safety Profile
Common Vascular Reactions: Mild to moderate headaches, flushing (sudden warmth and redness of the face, neck, or upper chest), nasal congestion, sinus pressure, and occasional episodes of dizziness.
Gastrointestinal Disturbances: Dyspepsia (indigestion), mild abdominal discomfort, and nausea.
Serious Cardiovascular Warnings: Due to systemic vasodilation, it can trigger temporary drops in blood pressure. It is completely contraindicated for co-administration with organic nitrates or nitric oxide donors (e.g., nitroglycerin, amyl nitrite) because it can cause severe, life-threatening hypotension.Ophthalmological & Auditory Risks: Although rare due to its high PDE5 selectivity, any sudden decrease or loss of vision—associated with Non-Arterial Anterior Ischemic Optic Neuropathy (NAION)—or sudden hearing loss accompanied by tinnitus requires immediate cessation of the drug and urgent medical evaluation.Priapism Risks: Patients experiencing a prolonged, continuous erection lasting greater than 4 hours must seek emergency medical intervention to prevent permanent tissue damage and irreversible erectile loss.
Sourcing Documentation
Certificate of Analysis (COA): Verifying 200 mg ingredient purity, precise dissolution profiles, and freedom from manufacturing contaminants.
Detailed Batch Records: Documenting production origins, validated shelf-life metrics, and manufacturer testing data.
Global Logistics Manifests: Complete commercial invoices, precise packing specifications, and international air waybills tailored for secure pharmaceutical transport.
PRESCRIPTION MEDICINE IS :YES
Clinical Disclaimer : This technical document is intended solely for international distribution. Ava Force 200 mg tablets are high-potency medical formulations (PRESCRIPTION MEDICINE IS YES). This medication must be utilized strictly under the supervision of a licensed physician. It is strictly contraindicated in patients taking any form of nitrate medication, individuals with severe hepatic or renal impairment, those with a history of recent stroke or myocardial infarction (within the last 6 months), severe unstable angina, or known hypersensitivity to Avanafil.
📞 Contact Ernest Impex — Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
🌐 Websites:
📧 Email: exports@ernestpharmaceuticals.com
📦 Business Type: Exporter | Bulk Supplier | Distributor
📲 WhatsApp: +91 93599 02383
📲 WhatsApp Link: https://wa.me/919359902383
